Showing 1 - 10 of 7,503
action that evaluates patent validity. An economic incentive to challenge weak patents should also be introduced in Canada …
Persistent link: https://www.econbiz.de/10013074086
Persistent link: https://www.econbiz.de/10012433661
Persistent link: https://www.econbiz.de/10000931057
Persistent link: https://www.econbiz.de/10014282191
The established role of pharmaceutical products in the current health care landscape combined with increasing reports of serious and often fatal toxicity associated with these products have led to growing calls for reform of drug regulation. The growing public-private partnerships in research...
Persistent link: https://www.econbiz.de/10012752017
The apogee of anti-smoking legislation in North America was reached early in the last century. In 1903, the Canadian Parliament passed a resolution prohibiting the manufacture, importation, and sale of cigarettes. Around the same time, fifteen states in the United States banned the sale of...
Persistent link: https://www.econbiz.de/10014143324
This paper studies price determination in pharmaceutical markets using data for 25 countries, six years and a comprehensive list of products from the MIDAS IMS database. We show that market power and the quality of the product has a significantly positive impact of prices. The nationality of the...
Persistent link: https://www.econbiz.de/10014225237
To examine the extent to which Canadian residents seek medical care across the border, we collected data about Canadians' use of services from ambulatory care facilities and hospitals located in Michigan, New York State, and Washington State during 1994-1998. We also collected information from...
Persistent link: https://www.econbiz.de/10014116105
particular the Patent Act. The EC alleged that Canada’s legislation is not compatible with its obligations under the TRIPS …
Persistent link: https://www.econbiz.de/10012884077
Persistent link: https://www.econbiz.de/10011405941